Prognosis of advanced hepatocellular carcinoma: a new stratification of Barcelona Clinic Liver Cancer stage C: results from a French multicenter study.

Fiche publication


Date publication

avril 2016

Journal

European journal of gastroenterology & hepatology

Auteurs

Membres identifiés du Cancéropôle Est :
Pr BRONOWICKI Jean-Pierre


Tous les auteurs :
Adhoute X, Pénaranda G, Raoul JL, Blanc JF, Edeline J, Conroy G, Perrier H, Pol B, Bayle O, Monnet O, Beaurain P, Muller C, Castellani P, Bronowicki JP, Bourlière M

Résumé

Advanced hepatocellular carcinoma (HCC) includes a wide spectrum of tumors and patients' prognosis after treatment is highly variable. Moreover, therapeutic options based on the Barcelona Clinic Liver Cancer (BCLC) staging system algorithm are restricted to one systemic therapy.

Mots clés

Aged, Algorithms, Angiogenesis Inhibitors, therapeutic use, Area Under Curve, Carcinoma, Hepatocellular, drug therapy, Chi-Square Distribution, Decision Support Techniques, Female, France, Humans, Kaplan-Meier Estimate, Liver Neoplasms, drug therapy, Male, Middle Aged, Multivariate Analysis, Neoplasm Staging, methods, Niacinamide, analogs & derivatives, Phenylurea Compounds, therapeutic use, Predictive Value of Tests, Proportional Hazards Models, ROC Curve, Reproducibility of Results, Retrospective Studies, Risk Assessment, Risk Factors, Treatment Outcome

Référence

Eur J Gastroenterol Hepatol. 2016 Apr;28(4):433-40